Sanofi Consumer Healthcare Complete Financial Statements
SANOFICONR • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2024 - 2023
Complete Financial Data Export
Export complete financial statements for Sanofi Consumer Healthcare (SANOFICONR).
Downloads include all available records across all periods.
For market performance, see the
SANOFICONR stock price today
.
Profitability Ratios
Net Profit Margin
24.53%
2024 data
EBITDA Margin
38.48%
2024 data
Operating Margin
37.00%
2024 data
Return on Assets
42.00%
2024 data
Return on Equity
66.30%
2024 data
Balance Sheet Ratios
Current Ratio
14.00
2024 data
Debt to Equity
1.58
2024 data
Equity Ratio
63.34%
2024 data
Asset Turnover
1.71
2024 data
Year-over-Year Growth Analysis
Comparing March 2024 vs Period
Revenue Growth
+11.7%
Year-over-Year
Net Profit Growth
+20.4%
Year-over-Year
EBITDA Growth
+7.0%
Year-over-Year
Expense Growth
+14.5%
Year-over-Year
Assets Growth
+24.9%
Year-over-Year
Equity Growth
+31.3%
Year-over-Year
Liabilities Growth
+24.9%
Year-over-Year
Financing Cash Flow Growth
-5900.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2024 | March 2023 |
|---|---|---|---|
| Revenue | 824 | 738 | 560 |
| Expenses | 520 | 454 | 337 |
| EBITDA | 304 | 284 | 223 |
| Operating Profit Margin % | 35.00% | 37.00% | 39.00% |
| Depreciation | 9 | 5 | 2 |
| Interest | 2 | 4 | 0 |
| Profit Before Tax | 293 | 247 | 219 |
| Tax | 76 | 66 | 54 |
| Net Profit | 218 | 181 | 165 |
| Earnings Per Share (₹) | 94.60 | 78.59 | 71.60 |
Related Pages for Sanofi Consumer Healthcare
Additional stock information and data for SANOFICONR
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2024 | 2023 |
|---|---|---|
| ASSETS | ||
| Total Assets | 431 | 345 |
| Current Assets | 392 | 335 |
| Fixed Assets | 29 | 5 |
| Capital Work in Progress | 1 | 3 |
| Investments | 0 | 0 |
| Other Assets | 402 | 338 |
| LIABILITIES | ||
| Total Liabilities | 431 | 345 |
| Current Liabilities | 28 | 8 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 273 | 208 |
| Share Capital | 23 | 2 |
| Reserves & Surplus | 250 | 183 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2024 | March 2023 |
|---|---|---|
| Operating Activities | 439 | 0 |
| Investing Activities | 2 | 0 |
| Financing Activities | -116 | 2 |
| Net Cash Flow | 325 | 2 |